Founded in 1992, the Needham, MA, Center of Excellence includes a clinic, research center, state-of-the-art manufacturing lab, and patient and family support center.

PROSE® by BostonSight is a medical treatment that uses highly customized scleral lens devices to restore visual and physiological function in patients with ocular surface disease, corneal disease, injury, or damage. For many patients, our treatment is their only option to restore their vision and end the suffering from critical and devastating eye issues.

BostonSight SCLERAL® expands global access to our scleral lens technology, optimizing scleral lens fitting, and increasing satisfaction for patients and practitioners. Practitioners can quickly and effectively help patients achieve optimal vision and comfort with our ready-to-fit scleral lens option.

Core Values

  • Compassionate, patient-centered experience

  • Excellence in all we do

  • Innovation

  • Expanding knowledge and education

  • Collaboration

  • Integrity

Our Vision

A world where no one suffers loss of sight from corneal irregularities or ocular surface disease.

Our Mission

To improve quality of life by transforming the understanding, treatment, and care of the ocular surface.

Our History

1985
1992
1994
1998
2005
2008
2016
2017
2018
2019
2020
2021
2021
2022
2023

Pioneers from the start

Developed the first fluid ventilated lens, which allows oxygen to permeate the lens via a new polymer material while oxygenated tears can flow beneath the lens.

BostonSight Founded

Clinic founded as the National Scleral Lens Foundation, later renamed Boston Foundation for Sight.

FDA Approval

First to obtain an FDA approval to use scleral lenses for therapeutic purposes, and first to use mathematical spline functions to customize scleral lens designs.

Design to Fit Software

Developed software to power the spline curve functions, which allowed BostonSight to customize scleral lens designs.

Restoring Sight Across the Globe

First Network Clinic established in India with LV Prasad

Expanding at Home

First U.S. Network Clinic established

FDA Clearance for BostonSight SCLERAL

Received FDA clearance for SCLERAL, BostonSight’s evidence-based lens designed to help patients with a range of issues improve eye condition and increase comfort.

Creating Efficiencies for Practitioners

BostonSight FitConnect® launches to give clinicians an easy, intuitive lens design tool and order management system all in one web-based platform.

Leading the Industry in Education & Research

BostonSight named the #1 contributor to scleral peer-reviewed publications in the U.S. and #2 worldwide.

Keeping Quality in Sight

Began offering SmartSight® HOA Technology to mitigate effects of Higher Order Aberrations and improve visual quality for patients.

Introduced SCLERALIG, BostonSight’s latest innovation

Uses image topography to map the eye.

BostonSight SCLERAL expands

Moves into the Latin American marketing with a distributor partnership with Spectrum International.

Announced two FitKits®

FitKits® cover a range of diameters from 16-19mm.

Launched Smart360®, replacing SCLERALIG

Uses image topography to map the eye for a truly custom scleral lens fit.

BostonSight SCLERAL continues global expansion

Signs licensing agreements with Moorfields National Health Service in the UK and Conoptica in Spain, a subsidiary of Hecht International.